- Home
- ORMP vs ONCY Comparison
ORMP vs ONCY Comparison
Compare ORMP & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- ONCY
- Stock Information
- Founded
- ORMP 2002
- ONCY 1998
- Country
- ORMP United States
- ONCY Canada
- Employees
- ORMP N/A
- ONCY N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- ONCY Pharmaceuticals and Biotechnology
- Sector
- ORMP Health Care
- ONCY Health Care
- Exchange
- ORMP Nasdaq
- ONCY Nasdaq
- Market Cap
- ORMP 104.6M
- ONCY 89.7M
- IPO Year
- ORMP N/A
- ONCY 1999
- Fundamental
- Price
- ORMP $2.23
- ONCY $1.18
- Analyst Decision
- ORMP
- ONCY Strong Buy
- Analyst Count
- ORMP 0
- ONCY 5
- Target Price
- ORMP N/A
- ONCY $5.00
- AVG Volume (30 Days)
- ORMP 135.7K
- ONCY 923.5K
- Earning Date
- ORMP 11-06-2025
- ONCY 11-11-2025
- Dividend Yield
- ORMP N/A
- ONCY N/A
- EPS Growth
- ORMP N/A
- ONCY N/A
- EPS
- ORMP N/A
- ONCY N/A
- Revenue
- ORMP $2,000,000.00
- ONCY N/A
- Revenue This Year
- ORMP N/A
- ONCY N/A
- Revenue Next Year
- ORMP N/A
- ONCY N/A
- P/E Ratio
- ORMP N/A
- ONCY N/A
- Revenue Growth
- ORMP N/A
- ONCY N/A
- 52 Week Low
- ORMP $1.82
- ONCY $0.33
- 52 Week High
- ORMP $3.09
- ONCY $1.51
- Technical
- Relative Strength Index (RSI)
- ORMP 40.47
- ONCY 43.36
- Support Level
- ORMP $2.19
- ONCY $1.14
- Resistance Level
- ORMP $2.47
- ONCY $1.26
- Average True Range (ATR)
- ORMP 0.13
- ONCY 0.07
- MACD
- ORMP -0.04
- ONCY -0.03
- Stochastic Oscillator
- ORMP 10.20
- ONCY 13.67
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.